| |
| |
|
| Insider
Information: |
Sing George L |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,472 |
|
|
Indirect Shares
|
2,150 |
|
|
| Direct
Value |
$26,645,368 |
|
|
|
Indirect Value
|
$2,085,307 |
|
|
| Total
Shares |
29,622 |
|
|
| Total
Value |
$28,730,674 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
34
|
|
Stock
price went up :
|
0
|
17
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 3.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-05-03 |
27,472 |
2024-05-03 |
2,150 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
– • – |
2006-01-09 |
4 |
OE |
$7.66 |
$374,420 |
D/D |
40,000 |
112,772 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-25 |
4 |
S |
$600.36 |
$19,888,518 |
D/D |
(32,750) |
64,415 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-20 |
4 |
S |
$615.48 |
$12,955,042 |
D/D |
(21,000) |
104,415 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-24 |
4 |
S |
$592.27 |
$11,894,577 |
D/D |
(20,037) |
84,415 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-21 |
4 |
S |
$605.04 |
$12,080,040 |
D/D |
(19,963) |
94,415 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2011-11-22 |
4 |
OE |
$28.81 |
$432,150 |
D/D |
15,000 |
147,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2014-02-14 |
4 |
OE |
$9.17 |
$137,550 |
D/D |
15,000 |
127,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2014-02-14 |
4 |
S |
$324.00 |
$4,860,000 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2014-02-21 |
4 |
S |
$338.00 |
$5,085,000 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2014-02-21 |
4 |
OE |
$15.80 |
$237,000 |
D/D |
15,000 |
117,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-02-20 |
4 |
S |
$423.12 |
$6,346,800 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-02-20 |
4 |
OE |
$18.61 |
$279,150 |
D/D |
15,000 |
127,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2018-01-02 |
4 |
OE |
$23.84 |
$357,600 |
D/D |
15,000 |
134,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-01-02 |
4 |
OE |
$24.41 |
$366,150 |
D/D |
15,000 |
130,095 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-01-02 |
4 |
AS |
$371.98 |
$5,579,700 |
D/D |
(15,000) |
115,095 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2018-05-10 |
4 |
S |
$285.00 |
$3,726,000 |
D/D |
(13,000) |
114,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-25 |
4 |
OE |
$273.67 |
$3,489,293 |
D/D |
12,750 |
97,165 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-24 |
4 |
OE |
$177.82 |
$1,784,779 |
D/D |
10,037 |
104,452 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-11-13 |
4 |
B |
$18.78 |
$187,800 |
D/D |
10,000 |
122,772 |
2.39 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-12-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-11-26 |
4 |
S |
$295.00 |
$2,950,000 |
D/D |
(10,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-11-26 |
4 |
OE |
$15.01 |
$150,100 |
D/D |
10,000 |
122,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-20 |
4 |
OE |
$57.11 |
$571,100 |
D/D |
10,000 |
114,415 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-31 |
4 |
S |
$610.45 |
$6,120,555 |
D/D |
(10,000) |
54,415 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
